These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

622 related articles for article (PubMed ID: 9916804)

  • 1. Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides.
    Marsh DJ; Hollopeter G; Huszar D; Laufer R; Yagaloff KA; Fisher SL; Burn P; Palmiter RD
    Nat Genet; 1999 Jan; 21(1):119-22. PubMed ID: 9916804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass.
    Chen AS; Marsh DJ; Trumbauer ME; Frazier EG; Guan XM; Yu H; Rosenblum CI; Vongs A; Feng Y; Cao L; Metzger JM; Strack AM; Camacho RE; Mellin TN; Nunes CN; Min W; Fisher J; Gopal-Truter S; MacIntyre DE; Chen HY; Van der Ploeg LH
    Nat Genet; 2000 Sep; 26(1):97-102. PubMed ID: 10973258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome.
    Fan W; Boston BA; Kesterson RA; Hruby VJ; Cone RD
    Nature; 1997 Jan; 385(6612):165-8. PubMed ID: 8990120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-obese and obese agouti mice are sensitive to the anorectic effects of peptide YY(3-36) but resistant to ghrelin.
    Martin NM; Small CJ; Sajedi A; Patterson M; Ghatei MA; Bloom SR
    Int J Obes Relat Metab Disord; 2004 Jul; 28(7):886-93. PubMed ID: 15148507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperphagia, not hypometabolism, causes early onset obesity in melanocortin-4 receptor knockout mice.
    Weide K; Christ N; Moar KM; Arens J; Hinney A; Mercer JG; Eiden S; Schmidt I
    Physiol Genomics; 2003 Mar; 13(1):47-56. PubMed ID: 12644632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binge eating as a major phenotype of melanocortin 4 receptor gene mutations.
    Branson R; Potoczna N; Kral JG; Lentes KU; Hoehe MR; Horber FF
    N Engl J Med; 2003 Mar; 348(12):1096-103. PubMed ID: 12646666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that orexigenic effects of melanocortin 4 receptor antagonist HS014 are mediated by neuropeptide Y.
    Kask A; Rägo L; Korrovits P; Wikberg JE; Schiöth HB
    Biochem Biophys Res Commun; 1998 Jul; 248(2):245-9. PubMed ID: 9675121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mode of leptin action in chicken hypothalamus.
    Dridi S; Swennen Q; Decuypere E; Buyse J
    Brain Res; 2005 Jun; 1047(2):214-23. PubMed ID: 15907812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripherally administered [Nle4,D-Phe7]-alpha-melanocyte stimulating hormone increases resting metabolic rate, while peripheral agouti-related protein has no effect, in wild type C57BL/6 and ob/ob mice.
    Hoggard N; Rayner DV; Johnston SL; Speakman JR
    J Mol Endocrinol; 2004 Dec; 33(3):693-703. PubMed ID: 15591028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothalamic orexin, OX1, alphaMSH, NPY and MCRs expression in dopaminergic D2R knockout mice.
    García-Tornadú I; Díaz-Torga G; Risso GS; Silveyra P; Cataldi N; Ramirez MC; Low MJ; Libertun C; Becu-Villalobos D
    Neuropeptides; 2009 Aug; 43(4):267-74. PubMed ID: 19570576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aged-obese rats exhibit robust responses to a melanocortin agonist and antagonist despite leptin resistance.
    Zhang Y; Matheny M; Tümer N; Scarpace PJ
    Neurobiol Aging; 2004; 25(10):1349-60. PubMed ID: 15465633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular determination of agouti-related protein binding to human melanocortin-4 receptor.
    Yang Y; Chen M; Lai Y; Gantz I; Yagmurlu A; Georgeson KE; Harmon CM
    Mol Pharmacol; 2003 Jul; 64(1):94-103. PubMed ID: 12815165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of neuropeptide Y-deficient mice to feeding effectors.
    Hollopeter G; Erickson JC; Seeley RJ; Marsh DJ; Palmiter RD
    Regul Pept; 1998 Sep; 75-76():383-9. PubMed ID: 9802433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of in vivo and in vitro administration of ghrelin, leptin and neuropeptide mediators on pulsatile gonadotrophin-releasing hormone secretion from male rat hypothalamus before and after puberty.
    Lebrethon MC; Aganina A; Fournier M; Gérard A; Parent AS; Bourguignon JP
    J Neuroendocrinol; 2007 Mar; 19(3):181-8. PubMed ID: 17280591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadotropin-releasing hormone II (GnRH II) mediates the anorexigenic actions of α-melanocyte-stimulating hormone (α-MSH) and corticotropin-releasing hormone (CRH) in goldfish.
    Kang KS; Shimizu K; Azuma M; Ui Y; Nakamura K; Uchiyama M; Matsuda K
    Peptides; 2011 Jan; 32(1):31-5. PubMed ID: 20955748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diet-induced obesity causes severe but reversible leptin resistance in arcuate melanocortin neurons.
    Enriori PJ; Evans AE; Sinnayah P; Jobst EE; Tonelli-Lemos L; Billes SK; Glavas MM; Grayson BE; Perello M; Nillni EA; Grove KL; Cowley MA
    Cell Metab; 2007 Mar; 5(3):181-94. PubMed ID: 17339026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of hypothalamic NPY, AgRP, MC4R, AND IL-6 mRNA levels in young Lewis rats with early-life diet-induced obesity.
    Stofkova A; Skurlova M; Kiss A; Zelezna B; Zorad S; Jurcovicova J
    Endocr Regul; 2009 Jul; 43(3):99-106. PubMed ID: 19817504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma concentrations of alpha-MSH, AgRP and leptin in lean and obese men and their relationship to differing states of energy balance perturbation.
    Hoggard N; Johnstone AM; Faber P; Gibney ER; Elia M; Lobley G; Rayner V; Horgan G; Hunter L; Bashir S; Stubbs RJ
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):31-9. PubMed ID: 15212642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of 40 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists and the agouti-related protein (AGRP) antagonist.
    Xiang Z; Litherland SA; Sorensen NB; Proneth B; Wood MS; Shaw AM; Millard WJ; Haskell-Luevano C
    Biochemistry; 2006 Jun; 45(23):7277-88. PubMed ID: 16752916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.